| Title |
Repurposing existing drugs for COVID-19: an endocrinology perspective
|
|---|---|
| Published in |
BMC Endocrine Disorders, September 2020
|
| DOI | 10.1186/s12902-020-00626-0 |
| Pubmed ID | |
| Authors |
Flavio A. Cadegiani |
X Demographics
The data shown below were collected from the profiles of 199 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 37 | 19% |
| Japan | 19 | 10% |
| United States | 8 | 4% |
| Austria | 2 | 1% |
| Canada | 1 | <1% |
| Sao Tome and Principe | 1 | <1% |
| Netherlands | 1 | <1% |
| Saint Barthélemy | 1 | <1% |
| United Kingdom | 1 | <1% |
| Other | 0 | 0% |
| Unknown | 128 | 64% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 193 | 97% |
| Practitioners (doctors, other healthcare professionals) | 4 | 2% |
| Scientists | 1 | <1% |
| Science communicators (journalists, bloggers, editors) | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 235 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 235 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 33 | 14% |
| Student > Master | 22 | 9% |
| Other | 18 | 8% |
| Researcher | 18 | 8% |
| Student > Ph. D. Student | 14 | 6% |
| Other | 34 | 14% |
| Unknown | 96 | 41% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 62 | 26% |
| Nursing and Health Professions | 23 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 4% |
| Biochemistry, Genetics and Molecular Biology | 7 | 3% |
| Neuroscience | 6 | 3% |
| Other | 26 | 11% |
| Unknown | 102 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 142. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 June 2023.
All research outputs
#296,535
of 25,779,988 outputs
Outputs from BMC Endocrine Disorders
#9
of 880 outputs
Outputs of similar age
#8,915
of 434,850 outputs
Outputs of similar age from BMC Endocrine Disorders
#2
of 25 outputs
Altmetric has tracked 25,779,988 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 880 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,850 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.